Antimicrobial susceptibility of Streptococcus suis isolated from swine in France and from humans in different countries between 1996 and 2000

Size: px
Start display at page:

Download "Antimicrobial susceptibility of Streptococcus suis isolated from swine in France and from humans in different countries between 1996 and 2000"

Transcription

1 Journal of Antimicrobial Chemotherapy (2002) 50, DOI: /jac/dkf099 Antimicrobial susceptibility of Streptococcus suis isolated from swine in France and from humans in different countries between 1996 and 2000 J. Marie 1, H. Morvan 2, F. Berthelot-Hérault 1, P. Sanders 3, I. Kempf 1, A. V. Gautier-Bouchardon 1, E. Jouy 1 and M. Kobisch 1 * 1 Agence Française de Sécurité Sanitaire des Aliments, Laboratoire d Etudes et de Recherches Avicoles et Porcines, Unité Mycoplasmologie-Bactériologie, BP 53, F Ploufragan; 2 Laboratoire de Développement et d Analyses, Zoopôle, 7 rue du Sabot, BP 54, F Ploufragan; 3 Agence Française de Sécurité Sanitaire des Aliments, Laboratoire d Etudes et de Recherches sur les Médicaments Vétérinaires et les Désinfectants, La Haute Marche, Javené, F Fougères, France Received 23 August 2001; returned 26 November 2001; revised 18 April 2002; accepted 29 April 2002 The susceptibility of 135 Streptococcus suis strains isolated from pigs (n = 110) and from humans (n = 25) to 13 antimicrobial agents was studied by microdilution and disc diffusion methods using Mueller Hinton Agar II (MH) supplemented with either defibrinated sheep blood (MHSB) or horse serum (MHHS). Results were similar for both methods used except for penicillin G whose zone diameters were reduced with MHSB compared with MHHS. When MH was supplemented with sheep blood, 39% of S. suis strains classified as penicillin susceptible by MHHS microdilution showed intermediate susceptibility. Nearly all strains were susceptible to penicillin G (except by disc diffusion in MHSB), amoxicillin, ceftiofur, florfenicol, gentamicin and bacitracin. The least active antimicrobial agents were doxycycline and macrolides/lincosamides. High-level resistance (MIC > 500 mg/l or zone diameters < 10 mm) to streptomycin and kanamycin was detected in only a few strains. The virulence of strains did not seem to be related to antimicrobial resistance because no statistical difference was reported between the proportion of resistant strains of S. suis isolated from pigs with meningitis, septicaemia and arthritis, and those from tonsils and nasal cavities. However, significant differences were found in the proportions of macrolide- or doxycycline-resistant strains between S. suis serotype 2 and other serotypes. The results of antibiotic susceptibility testing presented in this study indicate that β-lactams can be used in empirical treatment of human and pig S. suis infections in France. Introduction Streptococcus suis is an important swine pathogen causing meningitis, arthritis, septicaemia and endocarditis, but these bacteria can also be isolated from nasal cavities or tonsils of healthy pigs. 1,2 Moreover, S. suis is a zoonotic agent and may cause meningitis in humans. 3 S. suis is divided into 35 serotypes, according to its polysaccharide capsular antigens. Virulence differs within the serotypes, serotype 2 being the serotype most often associated with disease. 1 Autogenous vaccines are used to protect swine against S. suis infections but since protection is incomplete, different types of vaccine are under investigation. 2 Among antimicrobial agents for treatment and prevention, the most active are the β-lactams, aminoglycosides, phenicols and fluoroquinolones. 4 Previous studies have investigated the antimicrobial susceptibility of clinical isolates but few have reported the susceptibility of S. suis strains isolated from healthy pigs. 5 Most reports of resistance concentrate on streptococci, notably Streptococcus pneumoniae. 6 9 Shneerson et al. 10 described a case of human meningitis with a penicillin-resistant S. suis. β-lactam-resistant S. suis strains have also been isolated from swine in Spain. 11 According to Gottschalk et al., 12 resistance has not been associated with the production of β-lactamase. More recently, resistance of S. suis to different antibiotics has been described. 1,2... *Corresponding author. Tel: ; Fax: ; m.kobisch@ploufragan.afssa.fr The British Society for Antimicrobial Chemotherapy

2 J. Marie et al. We have undertaken a study to determine the antimicrobial susceptibility of 110 S. suis strains isolated in France from 1996 to 2000, from diseased as well as from healthy pigs, testing 13 antimicrobial agents by agar diffusion and microdilution methods. Twenty-five strains isolated from humans were also analysed. Materials and methods Antimicrobial susceptibility testing was carried out on all strains by disc diffusion and microdilution tests according to recommendations reported by the Comité de l Antibiogramme de la Société Française de Microbiologie (CA- SFM). 13,14 Bacterial strains Eighty-three S. suis strains collected from diseased pigs presenting with septicaemia, meningitis or arthritis, and 27 strains isolated from tonsils or nasal cavities of healthy pigs were tested in the study. Twenty-five S. suis strains isolated from humans from Canada (four strains), England (one strain), France (seven strains), the Netherlands (11 strains) and Mexico (two strains) were also included. Among these human strains, 24 were associated with pyrexia, meningitis, endocarditis or spondylitis, and one was isolated from a healthy human. 15 Identification and serotyping of S. suis were performed as described by Gottschalk et al. 16 The following reference strains were used for each batch of antimicrobial testing by both methods: Staphylococcus aureus ATCC 25923, Enterococcus faecalis ATCC 29212, Escherichia coli ATCC and Pseudomonas aeruginosa ATCC Antimicrobial susceptibility testing Disc diffusion method (DDM). The culture medium was Mueller Hinton (MH) agar supplemented with 5% defibrinated sheep blood [MHSB (AES, Combourg, France) as recommended by the CA-SFM for streptococci 14 but also by the NCCLS 17 ] or with 5% horse serum [MHHS (Life- Technologies, Cergy-Pontoise, France)]. The antimicrobial agents used in this study were: β-lactams: penicillin G (6 µg), amoxicillin (25 µg), ceftiofur (30 µg); aminoglycosides: streptomycin (500 µg), kanamycin (1000 µg), gentamicin (500 µg); polypeptides: bacitracin (10 IU); tetracyclines: doxycycline (30 IU); macrolides/ lincosamides: erythromycin (15 IU), spiramycin (100 µg), lincomycin (15 µg) (Bio-Rad, Marnes la Coquette, France), tylosin (30 µg) (Lilly-France, Saint-Cloud, France); phenicols: florfenicol (30 µg) (Schering-Plough, Segré, France). The method used was in accordance with CA-SFM recommendations. 13,14 Briefly, three or four colonies from an overnight culture on Columbia agar supplemented with 5% sheep blood (AES) were suspended in MH broth (Becton Dickinson, Pont de Claix, France). The suspension was adjusted to a 0.5 McFarland standard and diluted to obtain an inoculum of 10 6 cfu/ml S. suis. For each strain two plates were inoculated by flooding MH agar (4 mm depth) supplemented with either 5% defibrinated sheep blood or 5% horse serum. The antibiotic discs were placed with a disc dispenser (Bio- Rad) and plates were incubated at 37 C in 5% CO 2 for 18 h. The zone diameters of S. suis strains and the reference strains were measured on the same day using a sliding caliper. Microdilution method (MDM). Susceptibility to antimicrobial agents was also determined by the MDM with MH broth supplemented with 5% horse serum using the following antimicrobial agents: penicillin G ( mg/l), amoxicillin ( mg/l), ceftiofur (1 64 mg/l), streptomycin ( mg/l), kanamycin ( mg/l), gentamicin ( mg/l), bacitracin (1 16 mg/l), doxycycline ( mg/l), erythromycin ( mg/l), spiramycin ( mg/l), tylosin ( mg/l), lincomycin ( mg/l) and florfenicol ( mg/l). All antimicrobial agents were purchased from Sigma (Saint Quentin Fallavier, France) except for ceftiofur (Pharmacia & Upjohn, Saint Quentin en Yvelines, France) and florfenicol (Schering- Plough). The antimicrobial solutions were prepared as described in the report of the CA-SFM, 14 and each dilution was distributed in 96-well microtitration plates (Merck Eurolab, Strasbourg, France). Bacterial suspensions were prepared as described for the DDM and adjusted to cfu/ml. The microtitration plates were incubated at 37 C in 5% CO 2 for 18 h. The MIC was defined as the lowest concentration of antibiotic that inhibited development of visible growth. Interpretation of susceptibility testing results A strain was considered susceptible if the zone diameter was greater than or equal to the diameter breakpoint for the DDM or if the MIC was smaller than or equal to the MIC breakpoint for the MDM. The antibiotic breakpoints were taken from the CA-SFM 13,14 and the NCCLS 17 reports except for florfenicol, for which the breakpoints used were those given by the manufacturer. The distributions of resistant (R), intermediate (I) or susceptible (S) strains were compared according to the three methods used and the agreement of these classifications was analysed for each strain. If a discord was detected, it was defined as major if a strain was classified S to an antimicrobial agent with one method and R with the other method. The discord was defined as minor if a strain was classified I to an antimicrobial agent with one method and S or R with the other method. 202

3 Antimicrobial susceptibility of Streptococcus suis Statistical analysis For each antimicrobial agent, the effects of capsular type and origin of S. suis on the antimicrobial susceptibility were analysed with Fisher s exact test. This test was also used for the evaluation of the medium effect (MHSB or MHHS) on the antimicrobial susceptibility determined by the DDM. In all cases, differences were considered significant when P was <0.05. Results The distribution of S. suis isolates according to serotype is presented in Tables 1 and 2. Sixty of the 110 strains (54.5%) isolated from pigs belonged to serotype 2. Most of them were associated with clinical signs and pathology: 55% with septicaemia, 50% with meningitis and 100% with arthritis. However, 44% of strains from healthy pigs were serotype 2. In humans, 96% of serotype 2 strains were associated with meningitis. The four reference strains presented zone diameters and MICs similar to those reported by the CA-SFM (Tables 3 and 4). Good agreement was obtained for results by the DDM using MHSB and MHHS media for all antimicrobial agents except for penicillin G. For this molecule, the population of S. suis strains was divided by the larger diameter breakpoint into two sub-populations with MHSB, whereas all but one strain were classified as susceptible with MHHS (Figure 1). Moreover, for the two reference strains susceptible to penicillin G (S. aureus ATCC and E. faecalis 29212), zone diameters were slightly smaller with MHHS than with MHSB. The other two reference strains were R to penicillin G and their zone diameters were identical with both media. According to S, I or R classification of strains, significant differences (P < 0.05) were noted between the DDM and the MDM for streptomycin and bacitracin. For streptomycin, only four strains were classified as R by DDM, and seven were classified as R and five as I by the MDM. For bacitracin, only one strain was classified as R by the DDM, whereas nine strains were R by the MDM (Tables 1 and 2). Minor discords were reported mainly for penicillin G. Fiftythree strains were classified as I by the DDM with MHSB (Figure 1a) and as S by the DDM with MHHS (Figure 1b) and by the MDM (Table 2). One strain was classified as I by the DDM (Figure 1b) and S by the MDM (Table 2). Minor differences were also observed for macrolides/lincosamides, streptomycin, kanamycin and doxycycline. For these last molecules two to 10 strains were classified differently by the DDM or MDM, and one to four strains were classified differently by diffusion in MHSB or MHHS. The numbers of susceptible S. suis strains according to the DDM and MDM are reported in Tables 1 and 2, respectively. A large proportion of S. suis strains was classified as R to doxycycline (79% with the DDM and MDM). Resistance to macrolides and lincosamides was also widespread: for erythromycin, spiramycin, tylosin and lincomycin, only about 30% of the strains were classified as S (Tables 1 and 2). Most of the strains were classified as S to streptomycin and kanamycin. All strains were classified as S to penicillin G (except by the DDM with MHSB), amoxicillin, ceftiofur, gentamicin and florfenicol. Most strains were also S to bacitracin (99% with the DDM and 93% with the MDM). No correlation (P 0.14) could be found between the proportions of S S. suis isolated from diseased pigs (n = 83), healthy pigs (n = 27) or humans (n = 25). However, S. suis strains isolated from humans were significantly more frequently S (P < 0.02) to erythromycin, spiramycin, tylosin, lincomycin and doxycycline than strains isolated from diseased pigs (meningitis, arthritis or septicaemia) or healthy pigs. The S. suis capsular type 2 strains (n = 85) were also significantly more frequently S than other serotypes (n = 50) to erythromycin, spiramycin, tylosin and lincomycin (45 46% versus 8%, P < ) and doxycycline (31% versus 4%, P < ). Discussion This study was undertaken in order to propose a standardized method for testing the antimicrobial sensitivity of S. suis. As the DDM is very commonly used in France, it was decided to evaluate this technique, using either MHSB or MHHS, and to compare it with the broth dilution test, which seems more usual in many other countries. The use of horse serum instead of sheep blood in the DDM seemed justified because the opacity of the medium due to supplementation with blood hinders precise measuring of zone diameters without opening the plates, a manipulation that might be dangerous with a zoonotic agent such as S. suis. Moreover, a large quantity of a single batch of horse serum can be stored at 20 C for periods up to 1 year, whereas sheep blood must be ordered regularly (several times a month), a feature that results in the use of many different batches of this component, which may influence the reproducibility of the test over time. It is important to underline that this study showed that the presence in MH of horse serum, compared with sheep blood, resulted in increased inhibitory zone diameters of S. suis when testing penicillin G. The difference reported might be explained by a modification of penicillin G diffusion in the medium according to the supplement used. This explanation is in agreement with the slightly different results obtained with S. aureus ATCC and E. faecalis ATCC strains. Andrews et al. 18 have also reported a difference in zone diameters for Gram-positive pathogens to dalfopristin/ 203

4 Table 1. Distribution of S. suis serotypes and number of susceptible S. suis isolates determined by disc diffusion Capsular types isolated from diseased pigs (n = 83) Septicaemia (n = 54) Meningitis (n = 22) Arthritis (n = 7) Capsular types isolated from healthy pigs (nasal cavity, tonsils) (n = 27) Capsular type isolated from humans (n = 25) ATB a BP b (mm) 1/2 c (n = 7) (n = 30) (n = 4) (n = 5) (n = 6) Aut d Total (n = 2) (n = 54) 1/2 (n = 1) 2 (n = 11) 7 (n = 3) 9 (n = 5) Aut Total 2 (n = 2) (n = 22) (n = 7) Total 1/2 (n = 7) (n = 2) 2 (n = 12) 3 7 Aut Total 2 (n = 2) (n = 6) (n = 5) (n = 27) (n = 25) Total (n = 25) 204 P e AMX XNL FFC B GEN STR KAN E SP TYL L DO J. Marie et al. a ATB, antibiotic: P, penicillin G; AMX, amoxicillin; XNL, ceftiofur; FFC, florfenicol; B, bacitracin; GEN, gentamicin; STR, streptomycin; KAN, kanamycin; E, erythromycin; L, lincomycin; SP, spiramycin; TYL, tylosin; DO, doxycycline. b Diameter breakpoint for susceptibility (the strains were classified as S when the zone diameters were superior or equal to the diameter breakpoint) according to guidelines 13,14 or manufacturers. c Serotype. d Autoagglutinable isolates. e For penicillin G, the first line reports the number of S strains by DDM with MHHS (horse serum), and the second line reports the number of S strains by DDM with MHSB (sheep blood). For all other antibiotics the number of S strains by DDM with MHHS is only reported (no statistical differences were observed between the two media).

5 Table 2. Distribution of S. suis serotypes and number of susceptible S. suis isolates determined by microdilution 205 ATB a BP b (mg/l) Capsular types isolated from diseased pigs (n = 83) Septicaemia (n = 54) Meningitis (n = 22) Arthritis (n = 7) 1/2 c Aut d Total (n = 7) (n = 30) (n = 4) (n = 5) (n = 6) (n = 2) (n = 54) 1/2 (n = 1) 2 (n = 11) 7 (n = 3) 9 (n = 5) Aut Total (n = 2) (n = 22) 2 (n = 7) Capsular types isolated from healthy pigs (nasal cavity, tonsils) (n = 27) Total 1/ Aut Total (n = 7) (n = 2) (n = 12) (n = 2) (n = 6) (n = 5) (n = 27) Capsular type isolated from humans (n = 25) P AMX XNL FFC B GEN STR KAN E SP TYL L DO (n = 25) Total (n = 25) Antimicrobial susceptibility of Streptococcus suis a ATB, antibiotic: P, penicillin G; AMX, amoxicillin; XNL, ceftiofur; FFC, florfenicol; B, bacitracin; GEN, gentamicin; STR, streptomycin; KAN, kanamycin; E, erythromycin; L, lincomycin; SP, spiramycin; TYL, tylosin; DO, doxycycline. b MIC breakpoint (the strains were classified as S when the MICs were inferior or equal to the MIC breakpoint) according to guidelines 13,14 or manufacturers. c Serotype. d Autoagglutinable isolates.

6 J. Marie et al. Table 3. Zone diameters (mm) obtained with the four reference strains, compared with CA-SFM 13,14 and NCCLS 17 breakpoints E. coli ATCC S. aureus ATCC P. aeruginosa ATCC E. faecalis ATCC ATB a R b CA-SFM NCCLS R CA-SFM NCCLS R CA-SFM NCCLS R CA-SFM NCCLS P AMX XLN FFC B GEN STR KAN E SP TYL L DO a ATB, antibiotic: P, penicillin G; AMX, amoxicillin; XNL, ceftiofur; FFC, florfenicol; B, bacitracin; GEN, gentamicin; STR, streptomycin; KAN, kanamycin; E, erythromycin; L, lincomycin; SP, spiramycin; TYL, tylosin; DO, doxycycline. b Results obtained in this study. Table 4. MICs (mg/l) obtained with the four reference strains, compared with CA-SFM 13,14 and NCCLS 17 breakpoints E. coli ATCC S. aureus ATCC P. aeruginosa ATCC E. faecalis ATCC ATB a R b CA-SFM NCCLS R CA-SFM NCCLS R CA-SFM NCCLS R CA-SFM NCCLS P 32 < > AMX XLN < < FFC 2 8 > B GEN < < STR >16 KAN > E >16 < > SP >16 16 >16 1 TYL >16 >32 1 >16 > L > > DO 0.5 <0.5 >16 8 a ATB, antibiotic: P, penicillin G; AMX, amoxicillin; XNL, ceftiofur; FFC, florfenicol; B, bacitracin; GEN, gentamicin; STR, streptomycin; KAN, kanamycin; E, erythromycin; L, lincomycin; SP, spiramycin; TYL, tylosin; DO, doxycycline. b Results obtained in this study. 206

7 Antimicrobial susceptibility of Streptococcus suis Figure 1. Distribution of zone diameters for penicillin G in MHSB (a) or MHHS (b) (n = 135 strains of S. suis). The vertical lines represent the zone diameter breakpoints defined by the CA-SFM 13,14 for streptococci except S. pneumoniae. S suis isolates were classified as: R (zone diameter < 8 mm), I (zone diameter 8 mm and < 29 mm) or S (zone diameter 29 mm). quinupristin: the presence of blood in the base medium (Iso- Sensitest agar) also resulted in reduced zone diameters for Staphylococcus cohni, Staphylococcus capitis, Staphylococcus warneri, Enterococcus gallinarum and for the reference strains used in their study (S. aureus NCTC 6571, S. aureus ATCC and E. faecalis ATCC 29212). Although the distribution of the strains for penicillin G susceptibility appeared monomodal whatever the medium used, when using MHSB the CA-SFM-recommended breakpoint (29 mm) cut the population into two categories (60% susceptible and 40% intermediate), whereas all but one strain appeared susceptible when the test was performed with MHHS. As reported by Acar & Goldstein, 19 from an epidemiological point of view, the breakpoint should fit within the limits of clusters of microbial organisms with comparable susceptibility. Thus, in our opinion, it would be judicious to advise laboratories to use horse serum in preferance to sheep blood as a supplement in MH for S. suis susceptibility testing by the DDM. All S. suis strains were found to be S to penicillin G (except by the DDM: 40% of strains were I with MHSB and only one strain was I with MHHS), amoxicillin, ceftiofur, florfenicol and gentamicin, and nearly all strains were S to bacitracin. These results are in accordance with many other studies that have described S. suis as mainly susceptible to these antimicrobial agents The efficacy of β-lactams and gentamicin indicates that these antibiotics can still be chosen empirically when S. suis pig infection is detected in France. Moreover, in human meningitis the usual antimicrobial treatment (β-lactams) should be effective. However, S. suis resistance to β-lactams has been reported, 11,12,25 and streptococcal resistance to β-lactams has been described largely for S. pneumoniae. 6 8,26,27 Resistance to macrolides/lincosamides and tetracyclines described in this study has also been described in the literature to varying degrees in different countries. In France, Morvan 28 reported that 19% of 400 S. suis strains were susceptible to spiramycin, 38% to lincomycin and 18% to tetracycline. In Spain, Reams et al. 25 reported that 33%, 32% and 19% of S. suis strains were susceptible to erythromycin, clindamycin and tetracycline, respectively. In Denmark, 20% of S. suis strains, isolated from 1995 to 1997, were resistant to erythromycin, spiramycin, tylosin and lincomycin and 44% to tetracycline. These high rates of resistance to macrolides/ lincosamides and to tetracyclines might be explained by intensive use of tylosin (growth promoter) and tetracycline (therapeutic) in Danish pig production between 1992 and Our study showed a high level of resistance to streptomycin and to kanamycin and confirmed the results published by other authors who also described this kind of resistance in varying degrees. 21,24,29,30 The differences observed between countries might be explained by different usage of antimicrobial agents but could also be due to methodological differences between studies. Standardization of susceptibility testing methods at an international level would facilitate comparisons. In our study, serotype 2 was found to be resistant to macrolides/lincosamides less frequently than other serotypes, 207

8 J. Marie et al. in agreement with results reported by Aarestrup et al. 23 However, these results are inconsistent with those reported previously by Cantin et al. 31 No explanation can be found for this difference. The difference between serotype susceptibility shown in our study could be explained by the fact that serotype 2 is considered to be the serotype most commonly associated with disease, 1 and most commonly isolated from healthy animals. Austin et al. 32 demonstrated that levels of colonization by antibiotic-resistant bacteria are related to antibiotic exposure and prevalence of bacteria. For a proportion of subjects treated, the proportion of resistance decreased when the prevalence of bacteria increased. This difference in resistance in relation to serotype may explain the difference in macrolide/ lincosamide and doxycycline susceptibility observed between human and pig strains, because all human strains tested belonged to serotype 2. In conclusion, this study showed the efficacy of β-lactams against French isolates of S. suis. However, reduced susceptibility or resistance to penicillin G in S. suis has been reported in other countries. 11,12,21,24 Therefore, it seems very important to monitor susceptibility of S. suis to penicillins, still the treatment of choice for human or pig S. suis infections. In France, the evolution of antibiotic susceptibility of S. suis will be surveyed using a novel epidemiological network, RESAP- ATH, which has been running since the beginning of the year The aim of this network is to collect results of susceptibility testing carried out by regional veterinary laboratories and thus to follow the evolution of resistance in common pathogenic bacteria from cattle, pigs and poultry. These laboratories routinely use the disc diffusion method described in this article and about 70% of them use sheep blood. Mechanisms of resistance detected by this network will be studied in our laboratory or in collaboration with other French research centres. Acknowledgements This research was supported by the Direction Générale de l Alimentation (DGAl), Ministère de l Agriculture et de la Pêche. References 1. Staats, J. J., Feder, I., Okwumabua, O. & Chengappa, M. M. (1997). Streptococcus suis: past and present. Veterinary Research Communications 21, Higgins, R. & Gottschalk, M. (1999). Streptococcal diseases. In Diseases of Swine, 8th edn (Straw, B. E., D Allaire, S., Mengeling, W. L. & Taylor, D. J., Eds), pp Iowa State University Press, Ames, IA, USA. 3. Arends, J. P. & Zanen, H. C. (1988). Meningitis caused by Streptococcus suis in humans. Reviews of Infectious Diseases 10, Euzeby, J. P. (1999). Streptococcus suis: a short review. Revue de Médecine Vétérinaire 150, Dee, S. A., Carlson, A. R., Winkelman, N. L. & Corey, M. M. (1993). Effect of management practices on the Streptococcus suis carrier rate in nursery swine. Journal of the American Veterinary Medical Association 203, Tomasz, A. (1997). Antibiotic resistance in Streptococcus pneumoniae. Clinical Infectious Diseases 24, Suppl. 1, S Manzor, O., Pawlak, J. & Saravolatz, L. (1999). In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 43, Granizo, J. J., Aguilar, L., Casal, J., Garcia-Rey, C., Dal-Re, R. & Baquero, F. (2000). Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain ( ). Journal of Antimicrobial Chemotherapy 46, Sahm, D. F., Karlowsky, J. A., Kelly, L. J., Critchley, I. A., Jones, M. E., Thornsberry, C. et al. (2001). Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. Antimicrobial Agents and Chemotherapy 45, Shneerson, J. M., Chattopadhyay, B., Murphy, M. F. & Fawcett, I. W. (1980). Permanent perceptive deafness due to Streptococcus suis type II infection. Journal of Laryngology and Otology 94, Prieto, C., Garcia, F. J., Suarez, P., Imaz, M. & Castro, J. M. (1994). Biochemical traits and antimicrobial susceptibility of Streptococcus suis isolated from slaughtered pigs. Zentralblatt für Veterinarmedizin, Reihe B 41, Gottschalk, M., Turgeon, P., Higgins, R., Beaudoin, M. & Bourgault, A. M. (1991). Susceptibility of Streptococcus suis to penicillin. Journal of Veterinary Diagnostic Investigations 3, Courvalin, P. & Soussy C. J., Eds. (1996). Comité de l Antibiogramme de la Société Française de Microbiologie guidelines. Clinical Microbiology and Infection 2, Suppl Soussy, C., Carret, G., Cavallo, J. D., Chardon, H., Chidiac, C., Choutet, P. et al. (2000). Comité de l Antibiogramme de la Société Française de Microbiologie. Communiqué Pathologie Biologie 48, Berthelot-Herault, F., Morvan, H., Keribin, A. M., Gottschalk, M. & Kobisch, M. (2000). Production of muraminidase-released protein (MRP), extracellular factor (EF) and suilysin by field isolates of Streptococcus suis capsular types 2, 1/2, 9, 7 and 3 isolated from swine in France. Veterinary Research 31, Gottschalk, M., Higgins, R., Jacques, M., Mittal, K. R. & Henrischen, J. (1989). Description of 14 new capsular types of Streptococcus suis. Journal of Clinical Microbiology 27, National Committee for Clinical Laboratory Standards. (1999). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals: Approved Standard M31-A. NCCLS, Wayne, PA. 18. Andrews, J. M., Ashby, J. P. & Wise, R. (1999). Study to assess the reliability of a disc diffusion method for determining the sensitivity of Gram-positive pathogens to dalfopristin/quinupristin. Journal of Antimicrobial Chemotherapy 43,

9 Antimicrobial susceptibility of Streptococcus suis 19. Acar, J. F. & Goldstein, F. W. (1996). In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp Lippincott, Williams and Wilkins, Baltimore, MD, USA. 20. Shryock, T. R., Mortensen, J. E. & Rhoads, L. R. (1992). Antibiotic susceptibility in Streptococcus suis. Current Therapeutic Research 52, Stuart, J. G., Zimmerer, E. J. & Maddux, R. L. (1992). Conjugation of antibiotic resistance in Streptococcus suis. Veterinary Microbiology 30, Tarradas, M. C., Arenas, A., Maldonado, A., Vicente, S., Miranda, A. & Perea, A. (1994). Susceptibility of Streptococcus suis to various antimicrobial agents. Zentralblatt für Veterinarmedizin, Reihe B 41, Aarestrup, F. M., Jorsal, S. E. & Jensen, N. E. (1998). Serological characterization and antimicrobial susceptibility of Streptococcus suis isolates from diagnostic samples in Denmark during 1995 and Veterinary Microbiology 60, Kataoka, Y., Yoshida, T. & Sawada, T. (2000). A 10-year survey of antimicrobial susceptibility of Streptococcus suis isolates from swine in Japan. Journal of Veterinary Medical Science 62, Reams, R. Y., Glickman, L. T., Harrington, D. D., Bowersock, T. L. & Thacker, H. L. (1993). Streptococcus suis infection in swine: a retrospective study of 256 cases. Part I. Epidemiologic factors and antibiotic susceptibility patterns. Journal of Veterinary Diagnostic Investigations 5, Hofmann, J., Cetron, M. S., Farley, M. M., Baughman, W. S., Facklam, R. R., Elliott, J. A. et al. (1995). The prevalence of drugresistant Streptococcus pneumoniae in Atlanta. New England Journal of Medicine 333, Baquero, F., Garcia-Rodriguez, J. A., Garcia de Lomas, J. & Aguilar, L. (1999). Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year ( ) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial Agents and Chemotherapy 43, Morvan, H. (1994). Sensibilité aux antibiotiques en élevage industriel. In Antimicrobials in Animal Intensive Production, pp European Symposium Proceedings. Institut Supérieur des Productions animales et des Industries Agro-alimentaires, Ploufragan, France. 29. Aarestrup, F. M., Rasmussen, S. R., Artursson, K. & Jensen, N. E. (1998). Trends in the resistance to antimicrobial agents of Streptococcus suis isolates from Denmark and Sweden. Veterinary Microbiology 63, Turgeon, P. L., Higgins, R., Gottschalk, M. & Beaudoin, M. (1994). Antimicrobial susceptibility of Streptococcus suis isolates. British Veterinary Journal 150, Cantin, M., Harel, J., Higgins, R. & Gottschalk, M. (1992). Antimicrobial resistance patterns and plasmid profiles of Streptococcus suis isolates. Journal of Veterinary Diagnostic Investigations 4, Austin, D. J., Kakehashi, M. & Anderson, R. M. (1997). The transmisssion dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption. Proceedings of the Royal Society of London. Series B. Biological Sciences 264,

10

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Routine internal quality control as recommended by EUCAST Version 3.1, valid from Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus

More information

Background and Plan of Analysis

Background and Plan of Analysis ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification

More information

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.

More information

Quality assurance of antimicrobial susceptibility testing

Quality assurance of antimicrobial susceptibility testing Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly

More information

Tel: Fax:

Tel: Fax: CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time) Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

Christiane Gaudreau* and Huguette Gilbert

Christiane Gaudreau* and Huguette Gilbert Journal of Antimicrobial Chemotherapy (1997) 39, 707 712 JAC Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter

More information

Jan A. Jacobs* and Ellen E. Stobberingh

Jan A. Jacobs* and Ellen E. Stobberingh Journal of Antimicrobial Chemotherapy (996) 37, 37-375 In-vitro antimicrobial susceptibility of the 'Streptococcus millerv group {Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius)

More information

Defining Resistance and Susceptibility: What S, I, and R Mean to You

Defining Resistance and Susceptibility: What S, I, and R Mean to You Defining Resistance and Susceptibility: What S, I, and R Mean to You Michael D. Apley, DVM, PhD, DACVCP Department of Clinical Sciences College of Veterinary Medicine Kansas State University Susceptible

More information

What s new in EUCAST methods?

What s new in EUCAST methods? What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062

More information

Determination of antibiotic sensitivities by the

Determination of antibiotic sensitivities by the Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,

More information

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain

More information

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter

More information

Annual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml)

Annual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml) Streptococcus pneumoniae Annual Report: 5 In 5, a total of, isolates of pneumococci were collected from 59 clinical microbiology laboratories across Canada. Of these, 733 (9.5%) were isolated from blood

More information

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013 Principles and Practice of Antimicrobial Susceptibility Testing Microbiology Technical Workshop 25 th September 2013 Scope History Why Perform Antimicrobial Susceptibility Testing? How to Perform an Antimicrobial

More information

Sales survey of Veterinary Medicinal Products containing Antimicrobials in France

Sales survey of Veterinary Medicinal Products containing Antimicrobials in France Sales survey of Veterinary Medicinal Products containing Antimicrobials in France - 2009 February 2011 Édition scientifique Sales survey of Veterinary Medicinal Products containing Antimicrobials in France

More information

ORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA

ORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA ORIGINAL ARTICLE In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000 2001 M. E. Jones 1, R. S. Blosser-Middleton

More information

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot

More information

Performance Information. Vet use only

Performance Information. Vet use only Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.

More information

MRSA surveillance 2014: Poultry

MRSA surveillance 2014: Poultry Vicky Jasson MRSA surveillance 2014: Poultry 1. Introduction In the framework of the FASFC surveillance, a surveillance of MRSA in poultry has been executed in order to determine the prevalence and diversity

More information

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007 GeNei Bacterial Antibiotic Sensitivity Teaching Kit Manual Cat No. New Cat No. KT68 106333 Revision No.: 00180705 CONTENTS Page No. Objective 3 Principle 3 Kit Description 4 Materials Provided 5 Procedure

More information

Chapter 2. Disk diffusion method

Chapter 2. Disk diffusion method Chapter 2. Disk diffusion method Tendencia, Eleonor A. Date published: 2004 To cite this document : Tendencia, E. A. (2004). Chapter 2. Disk diffusion method. In Laboratory manual of standardized methods

More information

Antimicrobial use and Antimicrobial resistance: chapter 6.7 and 6.8 of the OIE Terrestrial Animal Health

Antimicrobial use and Antimicrobial resistance: chapter 6.7 and 6.8 of the OIE Terrestrial Animal Health Workshop for OIE national Focal Points for Veterinary Products (2 nd cycle) Vienna (Austria), 20-22 November 2012 Antimicrobial use and Antimicrobial resistance: chapter 6.7 and 6.8 of the OIE Terrestrial

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

Received 10 November 2006/Returned for modification 9 January 2007/Accepted 17 July 2007

Received 10 November 2006/Returned for modification 9 January 2007/Accepted 17 July 2007 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2007, p. 3726 3730 Vol. 51, No. 10 0066-4804/07/$08.00 0 doi:10.1128/aac.01406-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Comparative

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

against Clinical Isolates of Gram-Positive Bacteria

against Clinical Isolates of Gram-Positive Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,

More information

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals VET01 5th Edition Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals This standard covers the current recommended methods for disk diffusion

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme

DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme Hanne-Dorthe Emborg Department of Microbiology and Risk Assessment National Food Institute, DTU Introduction The DANMAP

More information

J. W. Mouton, H. P. Endtz, J. G. den Hollander, N. van den Braak and H. A. Verbrugh

J. W. Mouton, H. P. Endtz, J. G. den Hollander, N. van den Braak and H. A. Verbrugh Journal of Antimicrobial Chemotherapy (1997) 39, Suppl. A, 75 80 JAC In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with

More information

VLLM0421c Medical Microbiology I, practical sessions. Protocol to topic J05

VLLM0421c Medical Microbiology I, practical sessions. Protocol to topic J05 Topic J05: Determination of susceptibility of bacteria to antimicrobial drugs, assessments of resistance factors For study: textbooks, www, keywords e. g. Diffusion disc test ; E-test ; dilution micromethod

More information

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.1 INTRODUCTION Microorganisms that cause infectious disease are called pathogenic microbes. Although

More information

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016 Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that

More information

The Pharmaceutical and Chemical Journal, 2018, 5(1): Research Article

The Pharmaceutical and Chemical Journal, 2018, 5(1): Research Article , 2018, 5(1):145-152 Available online www.tpcj.org Research Article ISSN: 2349-7092 CODEN(USA): PCJHBA In Search of the Truth about the Quality of Mueller Hinton Agar and Tested Antimicrobial Discs Daniela

More information

Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens

Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens Surveillance for antimicrobial resistance in enteric bacteria in Australian pigs and chickens Dr Pat Mitchell R & I Manager Production Stewardship APL CDC Conference, Melbourne June 2017 Dr Kylie Hewson

More information

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious

More information

CLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014

CLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014 vs. Olga Perovic, Principal Pathologist, Center for Opportunistic, Tropical and Hospital Infections, Associate Professor at WITS, Saturday, May 24, 2014 A not-for-profit membership organization, the Clinical

More information

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb.

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb. Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli CRL Training course in AST Copenhagen, Denmark 23-27th Feb. 2009 Methodologies E-test by AB-biodisk A dilution test based on the

More information

Main objectives of the EURL EQAS s

Main objectives of the EURL EQAS s EQAS Enterococci, Staphylococci and E. coli EURL workshop, April, 11 Lourdes García Migura Main objectives of the EURL EQAS s To improve the comparability of antimicrobial susceptibility testing (AST)

More information

THIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE.

THIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE. THIS ARTICLE IS SPONSORED BY THE MINNESOTA DAIRY HEALTH CONFERENCE. ST. PAUL, MINNESOTA UNITED STATES OF MINNESOTA Clinical Pharmacology - Reasonable and Not-So-Reasonable Applications in Dairy Cattle

More information

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? With the support of Wallonie-Bruxelles-International 1-1 In vitro evaluation of antibiotics : the antibiogram

More information

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium www.ivis.org Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium May 17-20, 2015 Fort Collins, CO, USA Reprinted in the IVIS website with the permission

More information

Antimicrobial Stewardship Strategy: Antibiograms

Antimicrobial Stewardship Strategy: Antibiograms Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide

More information

Version 1.01 (01/10/2016)

Version 1.01 (01/10/2016) CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be

More information

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee

Recommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee VICH GL27 (ANTIMICROBIAL RESISTANCE: PRE-APPROVAL) December 2003 For implementation at Step 7 - Final GUIDANCE ON PRE-APPROVAL INFORMATION FOR REGISTRATION OF NEW VETERINARY MEDICINAL PRODUCTS FOR FOOD

More information

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli CRL Campylobacter Workshop The 7th -8th of Oct. 2008 National Veterinary Institute Uppsala, Sweden Legislation The Commission has

More information

Understanding the Hospital Antibiogram

Understanding the Hospital Antibiogram Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital

More information

Antibiotics & Resistance

Antibiotics & Resistance What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed

More information

Practical approach to Antimicrobial susceptibility testing (AST) and quality control

Practical approach to Antimicrobial susceptibility testing (AST) and quality control Practical approach to Antimicrobial susceptibility testing (AST) and quality control A/Professor John Ferguson, Microbiologist & Infectious Diseases Physician, Pathology North, University of Newcastle,

More information

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه

More information

Antibacterial susceptibility testing

Antibacterial susceptibility testing Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several

More information

Antimicrobials & Resistance

Antimicrobials & Resistance Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)

More information

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017 Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,

More information

Comparison of tablets and paper discs for antibiotic sensitivity testing

Comparison of tablets and paper discs for antibiotic sensitivity testing J. clin. Path., 1975, 28, 983-988 Comparison of tablets and paper discs for antibiotic sensitivity testing D. F. J. BROWN' AND D. KOTHARI From the Division of Hospital Infection, Clinical Research Centre,

More information

BSAC antimicrobial susceptibility

BSAC antimicrobial susceptibility BSAC antimicrobial susceptibility testing - from Stokes to European harmonization to world? Derek Brown 23 March 2011 BSAC antimicrobial susceptibility testing ti pre-working Party BSAC meetings from the

More information

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,

More information

Jasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4

Jasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4 JOURNAL OF CLINICAL MICROBIOLOGY, June 2003, p. 2372 2377 Vol. 41, No. 6 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.6.2372 2377.2003 The World Health Organization s External Quality Assurance System Proficiency

More information

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

Int.J.Curr.Microbiol.App.Sci (2018) 7(8): International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.378

More information

Antimicrobial susceptibility of Salmonella, 2016

Antimicrobial susceptibility of Salmonella, 2016 susceptibility of Salmonella, 06 Hospital and community laboratories are requested to refer all Salmonella isolated from human salmonellosis cases to ESR for serotyping and the laboratory-based surveillance

More information

The Journal of Veterinary Medical Science

The Journal of Veterinary Medical Science Advance Publication The Journal of Veterinary Medical Science Accepted Date: Sep 0 J-STAGE Advance Published Date: Oct 0 FULL PAPER Bacteriology SEROTYPES, ANTIMICROBIAL SUSCEPTIBILITY, AND MINIMAL INHIBITORY

More information

Multiple drug resistance pattern in Urinary Tract Infection patients in Aligarh

Multiple drug resistance pattern in Urinary Tract Infection patients in Aligarh Multiple drug resistance pattern in Urinary Tract Infection patients in Aligarh Author(s): Asad U Khan and Mohd S Zaman Vol. 17, No. 3 (2006-09 - 2006-12) Biomedical Research 2006; 17 (3): 179-181 Asad

More information

ANTIMICROBIAL TESTING. with ALKA VITA (ALKAHYDROXY ) ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE

ANTIMICROBIAL TESTING. with ALKA VITA (ALKAHYDROXY ) ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE ANTIMICROBIAL TESTING with ALKA VITA (ALKAHYDROXY ) on ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS (MRSA) PSEUDOMONA AERUGINOSA ENTEROBACTER CLOACAE FINAL RESULTS OF ANTIBACTERIAL TESTS IN VITRO WITH THE PRODUCT

More information

Medical bacteriology Lecture 8. Streptococcal Diseases

Medical bacteriology Lecture 8. Streptococcal Diseases Medical bacteriology Lecture 8 Streptococcal Diseases Streptococcus agalactiae Beat haemolytic Lancifield group B Regularly resides in human vagina, pharynx and large inine Can be transferred to infant

More information

Susceptibility Testing

Susceptibility Testing APPLIED MICROBIOLOGY, Nov. 1969, p. 766-770 Copyright 1969 American Society for Microbiology Vol. 18, No. 5 Printed in U.S.A. Effect of Mixed Cultures on Antibiotic Susceptibility Testing AZRA SHAHIDI

More information

The Report referred to in Article 5 of Directive 92/117/EEC

The Report referred to in Article 5 of Directive 92/117/EEC LUXEMBOURG The Report referred to in Article 5 of Directive 92/117/EEC TRENDS AND SOURCES OF ZOONOSES AND ZOONOTIC AGENTS IN HUMANS, FOODSTUFFS, ANIMALS AND FEEDINGSTUFFS including information on foodborne

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines

Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines Antibiotic Resistance in the European Union Associated with Therapeutic use of Veterinary Medicines Report and Qualitative Risk Assessment by the Committee for Veterinary Medicinal Products Annex III Surveillance

More information

Concise Antibiogram Toolkit Background

Concise Antibiogram Toolkit Background Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions

More information

APPENDIX III - DOUBLE DISK TEST FOR ESBL

APPENDIX III - DOUBLE DISK TEST FOR ESBL Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January

More information

Antimicrobial Susceptibility Testing: The Basics

Antimicrobial Susceptibility Testing: The Basics Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories

More information

The epidemiology of antimicrobial resistance and the link between human and veterinary medicine

The epidemiology of antimicrobial resistance and the link between human and veterinary medicine The epidemiology of antimicrobial resistance and the link between human and veterinary medicine Prof. Dr. Jeroen Dewulf Jeroen.Dewulf@UGent.be Unit for Veterinary Epidemiology, Faculty of Veterinary Medicine

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

WHY IS THIS IMPORTANT?

WHY IS THIS IMPORTANT? CHAPTER 20 ANTIBIOTIC RESISTANCE WHY IS THIS IMPORTANT? The most important problem associated with infectious disease today is the rapid development of resistance to antibiotics It will force us to change

More information

Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck

Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck DONNA J. BLAZEVIC, M.P.H., MARILYN H. KOEPCKE, B.S., A JOHN M. MATSEN, M.D. Departments of Laboratory Medicine

More information

EARS Net Report, Quarter

EARS Net Report, Quarter EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased

More information

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be

More information

EUCAST-and CLSI potency NEO-SENSITABS

EUCAST-and CLSI potency NEO-SENSITABS EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme

More information

Gram-positive cocci Staphylococci and Streptococcia

Gram-positive cocci Staphylococci and Streptococcia Medical microbiology Laboratory Lab 8 Gram-positive cocci Staphylococci and Streptococcia Lecturer Maysam A Mezher Gram positive cocci 1-Staphylococcus. 2-Streptococcus. 3-Micrococcus The medically important

More information

European Antimicrobial Resistance Surveillance System (EARSS) in Scotland: 2004

European Antimicrobial Resistance Surveillance System (EARSS) in Scotland: 2004 European Antimicrobial Resistance Surveillance System (EARSS) in Scotland: 2004 SECOND ANNUAL REPORT MJ Coyne 1, SJ Dancer 1, G Edwards 2, 3, D Morrison 2. 1 Health Protection Scotland, 2 Scottish MRSA

More information

TERMS OF REFERENCE (June 1997, Reviewed 17/9/97) BACKGROUND. (opinion expressed on 05 February 1998)

TERMS OF REFERENCE (June 1997, Reviewed 17/9/97) BACKGROUND. (opinion expressed on 05 February 1998) Report of the Scientific Committee for Animal Nutrition on the Efficacy and Risk for Users of the Therapeutic Macrolides Antibiotics Tylosin and Spiramycin Used as Feed Additives (opinion expressed on

More information

Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) A report to ISC presented by Paul M. Tulkens representative of

More information

Original Article. Hossein Khalili a*, Rasool Soltani b, Sorrosh Negahban c, Alireza Abdollahi d and Keirollah Gholami e.

Original Article. Hossein Khalili a*, Rasool Soltani b, Sorrosh Negahban c, Alireza Abdollahi d and Keirollah Gholami e. Iranian Journal of Pharmaceutical Research (22), (2): 559-563 Received: January 2 Accepted: June 2 Copyright 22 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services

More information

ISO INTERNATIONAL STANDARD

ISO INTERNATIONAL STANDARD ITERATIOAL STADARD ISO 20776-2 First edition 2007-07-01 Clinical laboratory testing and in vitro diagnostic test systems Susceptibility testing of infectious agents and evaluation of performance of antimicrobial

More information

Animal Antibiotic Use and Public Health

Animal Antibiotic Use and Public Health A data table from Nov 2017 Animal Antibiotic Use and Public Health The selected studies below were excerpted from Pew s peer-reviewed 2017 article Antimicrobial Drug Use in Food-Producing Animals and Associated

More information

Project Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms

Project Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms Project Summary Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms Principal Investigators: Mindy Brashears, Ph.D., Texas Tech University Guy

More information

EDUCATIONAL COMMENTARY CURRENT METHODS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING

EDUCATIONAL COMMENTARY CURRENT METHODS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING Commentary provided by: Linsey Donner, MPH, CPH, MLS (ASCP) CM Assistant Professor, Microbiology and Serology College of Allied Health Professions, Division of Medical Laboratory Science University of

More information

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility

More information

Should we test Clostridium difficile for antimicrobial resistance? by author

Should we test Clostridium difficile for antimicrobial resistance? by author Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first

More information

Frank Møller Aarestrup

Frank Møller Aarestrup Danish Veterinary Laboratory Bacterial populations and resistance development: Intestinal tract of meat animals Frank Møller Aarestrup 12 Antibiotic production 10 Mill. Kg 8 6 4 2 0 50 52 54 56 58 60 62

More information